Matthew Winton - 03 Apr 2023 Form 3 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
COO
Signature
/s/ Matthew Winton
Issuer symbol
INZY
Transactions as of
03 Apr 2023
Net transactions value
$0
Form type
3
Filing time
04 Apr 2023, 08:31:36 UTC
Next filing
15 Mar 2024

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit Index: 24.1 Power of Attorney